• Home
  •  / Becton Dickinson

Becton Dickinson

OverviewSuggest Edit

Becton, Dickinson and Company (BD) is a global medical technology company that develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products. It operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment offers medication delivery and management solutions, diabetes care products, and pharmaceutical systems. The BD Life Sciences segment provides provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infection, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products. The company serves healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public.

TypePublic
Founded1897
HQFranklin Lakes, NJ, USMap
Websitebd.com
Employee Ratings3.7More
Overall CultureDMore
View Jobs (3)

Recent NewsAll News

Latest Updates

Employees (est.) (Sept 2019)70,093(-7%)
Job Openings3
Revenue (FY, 2020)$17.1 B(-1%)
Share Price (Jan 2021)$261.7 (+2%)
Cybersecurity ratingBMore

Key People/Management at Becton Dickinson

Tom Polen

Tom Polen

Chief Executive Officer and President
Simon D. Campion

Simon D. Campion

Executive Vice President and President, Interventional Segment
Gary Cohen

Gary Cohen

Executive Vice President, Global Health
John A. DeFord

John A. DeFord

Executive Vice President and Chief Technology Officer
Tony Ezell

Tony Ezell

President, North America and Chief Marketing Officer
Jerry Flasz

Jerry Flasz

Executive Vice President, Global Services and Chief Information Officer
Show more

Becton Dickinson Office Locations

Becton Dickinson has offices in Franklin Lakes, Andover, Billerica, Broken Bow and in 83 other locations
Franklin Lakes, NJ, US (HQ)
Howe Buidling, 1 Becton Dr
Andover, MA, US
200 Bulfinch Dr
Billerica, MA, US
296 Concord Rd #280
Broken Bow, NE, US
150 S 1st Ave
Burlington, NC, US
780 Plantation Dr
Canaan, CT, US
7 Grace Way
Show all (88)

Becton Dickinson Financials and Metrics

Becton Dickinson Revenue

Embed Graph
View revenue for all periods
Becton Dickinson's revenue was reported to be $17.12 b in FY, 2020
USD

Revenue (FY, 2020)

17.1b

Gross profit (FY, 2020)

7.6b

Gross profit margin (FY, 2020), %

44.3%

Net income (FY, 2020)

874.0m

EBIT (FY, 2020)

1.5b

Market capitalization (15-Jan-2021)

76.1b

Closing stock price (15-Jan-2021)

261.7

Cash (30-Sept-2020)

2.8b

EV

91.2b
Becton Dickinson's current market capitalization is $76.1 b.
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Revenue

12.1b16.0b17.3b17.1b

Revenue growth, %

(3%)32%8%

Cost of goods sold

6.2b8.7b9.0b9.5b

Gross profit

5.9b7.3b8.3b7.6b
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

3.1b4.2b4.3b4.2b4.2b4.4b4.2b4.3b3.9b

Cost of goods sold

1.5b2.6b2.3b2.2b2.2b2.3b2.2b2.5b2.2b

Gross profit

1.6b1.6b2.0b2.0b2.0b2.1b2.0b1.7b1.7b

Gross profit Margin, %

50%38%47%47%47%48%47%41%43%
show all
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Cash

14.2b1.1b536.0m2.8b

Accounts Receivable

1.7b2.3b2.3b2.4b

Prepaid Expenses

856.0m1.3b1.1b

Inventories

1.8b2.5b2.6b2.7b
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

1.1b1.3b1.4b943.0m686.0m523.0m560.0m2.4b2.9b

Accounts Receivable

2.0b2.3b2.2b2.2b2.3b2.2b2.1b2.2b2.0b

Prepaid Expenses

1.3b1.2b1.2b1.2b1.2b1.3b987.0m1.2b903.0m

Inventories

3.0b2.5b2.6b2.5b2.6b2.6b2.8b2.8b2.9b
show all
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

1.1b311.0m1.2b874.0m

Depreciation and Amortization

1.1b2.0b2.3b2.2b

Inventories

(46.0m)246.0m(149.0m)(125.0m)

Accounts Payable

134.0m867.0m(470.0m)205.0m
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Net Income

(136.0m)(148.0m)446.0m599.0m619.0m1.1b278.0m461.0m746.0m

Depreciation and Amortization

291.0m844.0m1.4b563.0m1.1b1.7b530.0m1.1b1.6b

Cash From Operating Activities

320.0m1.0b1.6b245.0m1.0b2.0b713.0m1.2b2.1b

Capital Expenditures

(178.0m)(391.0m)(588.0m)(167.0m)(362.0m)(599.0m)(173.0m)(395.0m)(597.0m)
show all
USDFY, 2017

Revenue/Employee

288.4k

Debt/Equity

1.5 x

Debt/Assets

0.5 x

Financial Leverage

2.9 x
Show all financial metrics

Becton Dickinson Operating Metrics

FY, 2016FY, 2017FY, 2018FY, 2019

Facilities

255 289 380 362

Facility Space, sq. ft.

19.80 m20.46 m24.66 m25.30 m

Facilities (Owned)

60 71 89

Facilities (Leased)

195 218 291
Show all operating metrics

Becton Dickinson Acquisitions / Subsidiaries

Company NameDateDeal Size
TVA MedicalJuly 09, 2018
C. R. BardDecember 29, 2017$25.02 b
Caesarea Medical ElectronicsApril 04, 2017
Cellular ResearchAugust 25, 2015
CareFusionMarch 17, 2015$12.54 b
CRISI Medical SystemsMarch 02, 2015
GenCell BiosystemsOctober 03, 2014
AlverixJanuary 07, 2014
Cato Software SolutionsMarch 12, 2013
Safety SyringesDecember 26, 2012
Show more

Becton Dickinson Revenue Breakdown

Embed Graph

Becton Dickinson revenue breakdown by business segment: 22.7% from Interventional, 24.9% from Life Sciences and 52.4% from Medical

Becton Dickinson revenue breakdown by geographic segment: 15.8% from Greater Asia, 56.3% from United States, 19.4% from Europe and 8.5% from Other

Human Capital Metrics

Source: uploads5.craft.co, www.bd.com, www.bd.com, www.bd.com
Embed Graph
Show all human capital metrics

Becton Dickinson Cybersecurity Score

Cybersecurity ratingPremium dataset

B

88/100

Learn more about our premium products
SecurityScorecard logo

Becton Dickinson Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

60-79

out of 100

Learn more about our premium products
CSRHub logo

Becton Dickinson Online and Social Media Presence

Becton Dickinson's Trends

Embed Graph

Becton Dickinson Company Culture

  • Overall Culture

    D

    58/100

  • CEO Rating

    D

    64/100

  • Compensation

    C+

    72/100

  • Diversity

    F

    50/100

Learn more on Comparably

Becton Dickinson News and Updates

January 12, 2021

Becton Dickinson stock rallies after upbeat revenue outlook

Shares of Becton Dickinson & Co. rallied 2.3% in premarket trading Tuesday, after the medical technology company provided an upbeat outlook for its first quarter. For the quarter ended Dec. 31, the company expects to report revenue of $5.3 billion, up 26% from a year ago and above the FactSet c…
December 16, 2020

As Vaccinations Begin, Becton Dickinson Eclipses 1 Billion Needle And Syringe Orders

Becton Dickinson has tallied “pandemic orders” for more than 1 billion injection devices from countries around the world with vaccinations against Covid-19 well underway.
December 09, 2020

Sterile Swab For DNA Collection market is set to witness increasing demand over 2020-2027 With Top Key Players are Copan Group, Medtronic, Becton Dickinson, Bio Mérieux, 3M, Medico

​Sterile swab for DNA collection is one of the important process in genetics. Moreover, the DNA swabs are collected for the process of DNA fingerprinting, DNA typing, and DNA profiling. Cotton swab, foam swab, and flock swabs are majorly utilized for DNA collection across the globe. Posted via Indus…
December 02, 2020

Becton Dickinson to invest $1.2 billion to expand pre-fillable syringe manufacturing capacity for COVID vaccination

Becton Dickinson & Co. said Wednesday it is planning to invest about $1.2 billion in pre-fillable syringe manufacturing capacity over the next four years. The Franklin Lakes, N.J.-based medical technology company said the money will be used to expand and upgrade manufacturing for advanced drug …
November 06, 2020

Bragar Eagel & Squire is Investigating Certain Officers and Directors of eHealth, Cabot Oil & Gas, Super Micro Computer, and Becton Dickinson and Encourages Investors to Contact the Firm

NEW YORK, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors of eHealth, Inc. (NASDAQ: EHTH), Cabot Oil & Gas Corporation (NYSE: COG), Super Micro Computer, Inc. (NASDAQ: SMCI),…
September 03, 2020

Medical Supplies And Equipments 2020 Global Market Analysis |Top Company Profiles Medtronic Inc., Becton Dickinson & Company, Baxter International Inc., Align Technology Inc., IDEXX Laboratories Inc., Henry Schein Inc., Cooper Companies Inc

A new market study, titled “Discover Global Medical Supplies And Equipments Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports. Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more

 Becton Dickinson Frequently Asked Questions

  • When was Becton Dickinson founded?

    Becton Dickinson was founded in 1897.

  • Who are Becton Dickinson key executives?

    Becton Dickinson's key executives are Tom Polen, Simon D. Campion and Gary Cohen.

  • How many employees does Becton Dickinson have?

    Becton Dickinson has 70,093 employees.

  • What is Becton Dickinson revenue?

    Latest Becton Dickinson annual revenue is $17.1 b.

  • What is Becton Dickinson revenue per employee?

    Latest Becton Dickinson revenue per employee is $244.2 k.

  • Who are Becton Dickinson competitors?

    Competitors of Becton Dickinson include Omnicell, Ra Medical Systems and 10X Genomics.

  • Where is Becton Dickinson headquarters?

    Becton Dickinson headquarters is located at Howe Buidling, 1 Becton Dr, Franklin Lakes.

  • Where are Becton Dickinson offices?

    Becton Dickinson has offices in Franklin Lakes, Andover, Billerica, Broken Bow and in 83 other locations.

  • How many offices does Becton Dickinson have?

    Becton Dickinson has 88 offices.